GSK583   

GtoPdb Ligand ID: 9134

Synonyms: GSK'583
Compound class: Synthetic organic
Comment: GSK583 is a potent and selective next generation inhibitor of receptor interacting serine/threonine kinase 2 (RIP2 kinase) [2]. It is compound 27 in [2] and compound 89 claimed in patent WO2011140442 [1]. GSK583 can be used as a tool compound to investigate the role played by RIP2 kinase in NOD1 and NOD2 mediated pathology.
2D Structure
Click here for structure editor
Physico-chemical Properties
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 96.12
Molecular weight 398.12
XLogP 4.52
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Canonical SMILES Fc1ccc2c(c1)c(n[nH]2)Nc1ccnc2c1cc(cc2)S(=O)(=O)C(C)(C)C
Isomeric SMILES Fc1ccc2c(c1)c(n[nH]2)Nc1ccnc2c1cc(cc2)S(=O)(=O)C(C)(C)C
InChI InChI=1S/C20H19FN4O2S/c1-20(2,3)28(26,27)13-5-7-16-14(11-13)17(8-9-22-16)23-19-15-10-12(21)4-6-18(15)24-25-19/h4-11H,1-3H3,(H2,22,23,24,25)
InChI Key XLOGLWKOHPIJLV-UHFFFAOYSA-N
No information available.
Mechanism Of Action and Pharmacodynamic Effects
The pathway signalling via NOD1 and NOD2 is implicated in several inflammatory disorders, including inflammatory bowel disease (IBD), rheumatoid arthritis, sarcoidosis and asthma. Activation of NOD1 and NOD2 stimulates the synthesis of pro-inflammatory mediators. RIP2 kinase is the convergence point for NOD1/NOD2 signalling, so represents novel target for pharmacological regulation of aberrant NOD1/NOD2 activation in inflammatory disease.